These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36827300)

  • 1. Is retina affected in Huntington's disease? Is optical coherence tomography a good biomarker?
    Dusek P; Kopal A; Brichova M; Roth J; Ulmanova O; Klempir J; Preiningerova JL
    PLoS One; 2023; 18(2):e0282175. PubMed ID: 36827300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.
    Kersten HM; Danesh-Meyer HV; Kilfoyle DH; Roxburgh RH
    J Neurol; 2015 Nov; 262(11):2457-65. PubMed ID: 26233693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington's disease as a potential biomarker.
    Gulmez Sevim D; Unlu M; Gultekin M; Karaca C
    Int Ophthalmol; 2019 Mar; 39(3):611-621. PubMed ID: 29435796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset.
    Schmid RD; Remlinger J; Abegg M; Hoepner R; Hoffmann R; Lukas C; Saft C; Salmen A
    Brain Behav; 2022 Jun; 12(6):e2592. PubMed ID: 35511084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.
    Andrade C; Beato J; Monteiro A; Costa A; Penas S; Guimarães J; Reis FF; Garrett C
    Mov Disord; 2016 Mar; 31(3):377-83. PubMed ID: 26853218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington's disease.
    Murueta-Goyena A; Del Pino R; Acera M; Teijeira-Portas S; Romero D; Ayala U; Fernández-Valle T; Tijero B; Gabilondo I; Gómez Esteban JC
    J Neurol; 2023 Aug; 270(8):3821-3829. PubMed ID: 37079031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography (OCT) study in Argentinean Huntington's disease patients.
    Gatto E; Parisi V; Persi G; Fernandez Rey E; Cesarini M; Luis Etcheverry J; Rivera P; Squitieri F
    Int J Neurosci; 2018 Dec; 128(12):1157-1162. PubMed ID: 29912591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease and neurovascular structure of retina.
    Amini E; Moghaddasi M; Habibi SAH; Azad Z; Miri S; Nilforushan N; Mirshahi R; Cubo E; Mohammadzadeh N; Rohani M
    Neurol Sci; 2022 Oct; 43(10):5933-5941. PubMed ID: 35771295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of cirrus high-definition spectral-domain optical coherence tomography clock-hour, deviation, and thickness maps in detecting photographic retinal nerve fiber layer abnormalities.
    Hwang YH; Kim YY; Kim HK; Sohn YH
    Ophthalmology; 2013 Jul; 120(7):1380-7. PubMed ID: 23541761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoreceptor layer thinning in idiopathic Parkinson's disease.
    Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
    Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humphrey matrix frequency doubling technology perimetry and optical coherence tomography measurement of the retinal nerve fiber layer thickness in both normal and ocular hypertensive subjects.
    Mastropasqua L; Brusini P; Carpineto P; Ciancaglini M; Di Antonio L; Zeppieri MW; Parisi L
    J Glaucoma; 2006 Aug; 15(4):328-35. PubMed ID: 16865011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography measurements in Huntington's disease: a systematic review and meta-analysis.
    Gouravani M; Fekrazad S; Mafhoumi A; Ashouri M; DeBuc DC
    J Neurol; 2024 Oct; 271(10):6471-6484. PubMed ID: 39187741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing differences in retinal and choroidal microvasculature and structure in individuals with Huntington's Disease compared to healthy controls: A cross-sectional prospective study.
    Joseph S; Robbins CB; Haystead A; Hemesath A; Allen A; Kundu A; Ma JP; Scott BL; Moore KPL; Agrawal R; Gunasan V; Stinnett SS; Grewal DS; Fekrat S
    PLoS One; 2024; 19(1):e0296742. PubMed ID: 38289919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
    Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
    Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection.
    Leung CK; Lam S; Weinreb RN; Liu S; Ye C; Liu L; He J; Lai GW; Li T; Lam DS
    Ophthalmology; 2010 Sep; 117(9):1684-91. PubMed ID: 20663563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.
    Winges KM; Werner JS; Harvey DJ; Cello KE; Durbin MK; Balcer LJ; Calabresi PA; Keltner JL
    J Neuroophthalmol; 2013 Dec; 33(4):322-9. PubMed ID: 24051419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fiber layer and macular inner retina measurements by spectral domain optical coherence tomograph in Indian eyes with early glaucoma.
    Rao HL; Babu JG; Addepalli UK; Senthil S; Garudadri CS
    Eye (Lond); 2012 Jan; 26(1):133-9. PubMed ID: 22079964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular ganglion cell/inner plexiform layer measurements by spectral domain optical coherence tomography for detection of early glaucoma and comparison to retinal nerve fiber layer measurements.
    Nouri-Mahdavi K; Nowroozizadeh S; Nassiri N; Cirineo N; Knipping S; Giaconi J; Caprioli J
    Am J Ophthalmol; 2013 Dec; 156(6):1297-1307.e2. PubMed ID: 24075422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease.
    Mukherjee N; McBurney-Lin S; Kuo A; Bedlack R; Tseng H
    PLoS One; 2017; 12(9):e0185242. PubMed ID: 28945811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.